The use of physical and animal models to assess bioavailability.
D000042:Absorption; D000818:Animals; D001241:Aspirin / Q000378:metabolism; D001702:Biopharmaceutics / Q000295:instrumentation; D004285:Dogs; D004304:Dosage Forms; D005753:Gastric Mucosa / Q000378:metabolism; D006168:Guinea Pigs; D000882:Haplorhini; D006801:Humans; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D007408:Intestinal Absorption; D007700:Kinetics; D051379:Mice; D008962:Models, Theoretical; D010316:Particle Size; D004364:Pharmaceutical Preparations / Q000592:standards; D051381:Rats; D012146:Rest; D012457:Salicylamides / Q000378:metabolism; D012995:Solubility; D013552:Swine; D013752:Tetracycline / Q000378:metabolism; D013997:Time Factors
D004304:Dosage Forms; D004364:Pharmaceutical Preparations; D012457:Salicylamides; D013752:Tetracycline; D001241:Aspirin